Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead of a competing shot from Merck & Co. The ...

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot. Merck's Vaxneuvance – formerly ...

The Food and Drug Administration approved Prevnar 20, Pfizer’s next-generation 20-valent pneumococcal conjugate vaccine, for treating infants and children under the age of 17. The announcement ...

Pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein); contains a total of 46.2mcg saccharides per 0.5mL; susp for IM inj; contains aluminum. After shipping, Prevnar 20 may arrive at ...

As Pfizer gears up for its next big vaccine launch in Prevnar 20, the company is touting positive top-line results for a co-administration trial with a seasonal flu shot. The results, coming just ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...